CoChat

New-Onset Diabetes in Covid-19

Open access

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

There is a bidirectional relationship between Covid-19 and diabetes. On the one hand, diabetes is associated with an increased risk of severe Covid-19. On the other hand, new-onset diabetes and severe metabolic complications of preexisting diabetes, including diabetic ketoacidosis and hyperosmolarity for which exceptionally high doses of insulin are warranted, have been observed in patients with Covid-19. These manifestations of diabetes pose challenges in clinical management and suggest a complex pathophysiology of Covid-19–related diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmc2018688

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

Items 701–800 of 808

Metadata

Authors
Rubino, F., Amiel, S. A., Zimmet, P., Alberti, G., Bornstein, S., Eckel, R. H., Mingrone, G., Boehm, B., Cooper, M. E., Chai, Z., Del Prato, S., Ji, L., Hopkins, D., Herman, W. H., Khunti, K., Mbanya, J.-C., & Renard, E.
Affiliations
  • King's College London (GB)
  • Monash University (AU)
  • Imperial College London (GB)
  • Technische Universität Dresden (DE)
  • University of Colorado Anschutz (US)
  • Agostino Gemelli University Polyclinic (IT)
  • Nanyang Technological University (SG)
  • University of Pisa, Pisa, Italy
  • Peking University (CN)
  • Kings Health Partners (GB)
  • University of Michigan (US)
  • University of Leicester (GB)
  • Université de Yaoundé I (CM)
  • University of Montpellier, Montpellier, France
Corresponding author
Rubino, Francesco
Venue
New England Journal of Medicine
Published
2020-08-20
Volume
383
Issue
8
Pages
789-790
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W3035586023
Cited by
801
References
5
Citations by year
2026: 17 · 2025: 31 · 2024: 58 · 2023: 112 · 2022: 199 · 2021: 258 · 2020: 124
FWCI
22.70
Type
journal article
Language
en
Open access
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
  • HAL (submittedVersion)
  • CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
  • Research Portal (King's College London) (submittedVersion, other-oa)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
  • Zurich Open Repository and Archive (University of Zurich)
Funders
  • Transcampus of Technische Universität Dresden & King’s College London
  • King’s College London, London, UK and Monash University, Melbourne Australia
  • Institute of Diabetes, Endocrinology, Obesity, King’s Health Partners
Topics
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
Keywords
new-onset diabetes, COVID-19 pandemic, diabetic ketoacidosis, hyperosmolar hyperglycemic state, severe COVID-19, insulin therapy
MeSH terms
Betacoronavirus, COVID-19, SARS-CoV-2, Diabetes Mellitus, Glucose, Humans, Pneumonia, Viral, Registries, Global Health, Coronavirus Infections, Diabetes Complications, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.